RSS affiliate on one side, lines sharpen between tribals, ‘converted’ section in Jharkhand

WITH FOUR months to go for the Lok Sabha elections, and a little longer to the…

FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients

The agency’s full approval may result in people enrolled in Medicare receiving anti-amyloid treatment.

Alzheimer’s Blockbuster Is Coming, but Slowly

The developers of Alzheimer’s drugs have worked hard to make treatment available to patients.

Alzheimer’s Blockbuster Is Coming, but Slowly

The developers of Alzheimer’s drugs have worked hard to make treatment available to patients.

Medicare Plans to Cover Alzheimer’s Drugs

Biogen and Eisai’s Leqembi is slated for full approval this summer.

Biogen Boss Turns Corner on Alzheimer’s Miscues

The biotech company needs to embark on a new growth path as former Sanofi CEO Chris…

FDA Rejects Lilly’s Alzheimer’s Drug Candidate, Seeks More Data

Business Health care Health The setback could delay the potential commercial introduction of a drug called…

A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.

Pharmaceutical companies may try to cap the price hike in future.

FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug Aduhelm

Robert Calif acknowledged that the agency made mistakes when it failed to properly document interactions with…

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

Health Medicare will not pay for a drug under a previously issued rule restricting use of…